Caplight Directory>Investors>Otsuka Pharmaceutical>Otsuka-pharmaceutical


Otsuka Pharmaceutical

Otsuka Pharmaceutical

Tokyo, Tokyootsuka.co.jp

Overview

Otsuka Pharmaceutical was established in 1964. At Otsuka Pharmaceutical, we are committed to a holistic approach to health and well-being of people and are striving to create innovative, thoroughly-original pharmaceutical and nutraceutical products based on our corporate philosophy "Otsuka-people creating new products for better health worldwide" . The company distributes pharmaceutical products and researches, develops and markets products for cardiovascular, gastrointestinal and central nervous system disorders, thereby developing innovative products and medical devices that address high unmet medical needs .

Year Founded

1921

Portfolio Companies

6

Investments

CompanyDateStageLead
Transcend BiologicsMar 2026M&ACo-investor
Atmo BiosciencesMar 2023Series BLead
Oui TherapeuticsAug 2022Series BLead
Atmo BiosciencesSep 2021Series ALead
Proteus Digital HealthOct 2018StrategicLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo, Tokyo
Year Founded1921

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.